Papers

5

Total Citations

119

H-Index

5

About

Dr. Kendrick Yim is a urologic oncologist whose research centers on minimally invasive surgical management of kidney and testicular cancers, with a particular focus on robotic-assisted techniques. His most impactful work investigates neoadjuvant sunitinib for renal cell carcinoma with inferior vena caval thrombus, demonstrating in a multicenter analysis (41 citations) that this approach decreases thrombus size and improves oncologic outcomes. Dr. Yim has been instrumental in advancing robotic partial nephrectomy for complex renal masses, showing through comparative studies that robotic approaches yield superior trifecta outcomes for T2a tumors (28 citations) and comparable functional results for patients with pre-existing chronic kidney disease (11 citations). His multicenter analysis of robotic partial nephrectomy for clinical T3a masses (34 citations) further expands the indications for minimally invasive surgery. Most recently, Dr. Yim has contributed contemporary perioperative outcomes data for open retroperitoneal lymph node dissection in testicular cancer, updating decade-old benchmarks. His work consistently demonstrates that robotic techniques can safely extend the boundaries of nephron-sparing surgery while maintaining oncologic efficacy.

Research Focus

Key Achievements

5
H-Index
5
Papers
119
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis
41 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 66
🏛 Institutions: University of California San Diego, Moores Cancer Center, Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago